{"entity":{"type":"insider","cik":"0001836354","url":"/insider/0001836354","json_url":"/insider/0001836354.json","name":"Machatha Stephen","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":5,"n_filings":4,"first":"2024-03-12","last":"2025-08-13","span_basis":"filed_date"},"name_variants":[{"name":"Machatha Stephen","source":"filing","n_filings":4,"first_seen":"2024-03-12","last_seen":"2025-08-13"}],"transactions":[{"id":4027915,"accession":"0000950170-25-108210","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-108210","line_url":"/filing/0000950170-25-108210#line-1","is_derivative":false,"issuer_cik":"0001341235","issuer_name":"Aldeyra Therapeutics, Inc.","issuer_ticker":"ALDX","issuer_name_source":null,"issuer_url":"/issuer/0001341235","owner_cik":"0001836354","owner_name":"Machatha Stephen","owner_display_name":"Machatha Stephen","owner_url":"/insider/0001836354","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":22073.0,"shares_display":"22,073","price_per_share":5.1517,"price_display":"5.15","price_state":"stated","total_value":113713.4741,"total_display":"113,713.47","total_whole":"113,713","shares_owned_after":221799.0,"shares_owned_after_display":"221,799","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-11","filed_date":"2025-08-13","scope":"insider"},{"id":2851591,"accession":"0000950170-24-097071","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-097071","line_url":"/filing/0000950170-24-097071#line-1","is_derivative":false,"issuer_cik":"0001341235","issuer_name":"Aldeyra Therapeutics, Inc.","issuer_ticker":"ALDX","issuer_name_source":null,"issuer_url":"/issuer/0001341235","owner_cik":"0001836354","owner_name":"Machatha Stephen","owner_display_name":"Machatha Stephen","owner_url":"/insider/0001836354","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16041.0,"shares_display":"16,041","price_per_share":4.7363,"price_display":"4.74","price_state":"stated","total_value":75974.9883,"total_display":"75,974.99","total_whole":"75,975","shares_owned_after":236771.0,"shares_owned_after_display":"236,771","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-12","filed_date":"2024-08-14","scope":"insider"},{"id":9213001,"accession":"0000950170-24-045113","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-045113","line_url":"/filing/0000950170-24-045113#line-1","is_derivative":false,"issuer_cik":"0001341235","issuer_name":"Aldeyra Therapeutics, Inc.","issuer_ticker":"ALDX","issuer_name_source":null,"issuer_url":"/issuer/0001341235","owner_cik":"0001836354","owner_name":"Machatha Stephen","owner_display_name":"Machatha Stephen","owner_url":"/insider/0001836354","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11537.0,"shares_display":"11,537","price_per_share":3.164,"price_display":"3.16","price_state":"stated","total_value":36503.068,"total_display":"36,503.07","total_whole":"36,503","shares_owned_after":252812.0,"shares_owned_after_display":"252,812","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-12","filed_date":"2024-04-17","scope":"insider"},{"id":2303517,"accession":"0000950170-24-030311","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-030311","line_url":"/filing/0000950170-24-030311#line-2","is_derivative":false,"issuer_cik":"0001341235","issuer_name":"Aldeyra Therapeutics, Inc.","issuer_ticker":"ALDX","issuer_name_source":null,"issuer_url":"/issuer/0001341235","owner_cik":"0001836354","owner_name":"Machatha Stephen","owner_display_name":"Machatha Stephen","owner_url":"/insider/0001836354","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11537.0,"shares_display":"11,537","price_per_share":3.164,"price_display":"3.16","price_state":"stated","total_value":36503.068,"total_display":"36,503.07","total_whole":"36,503","shares_owned_after":243495.0,"shares_owned_after_display":"243,495","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-12","filed_date":"2024-03-12","scope":"insider"},{"id":2303512,"accession":"0000950170-24-030311","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-030311","line_url":"/filing/0000950170-24-030311#line-1","is_derivative":false,"issuer_cik":"0001341235","issuer_name":"Aldeyra Therapeutics, Inc.","issuer_ticker":"ALDX","issuer_name_source":null,"issuer_url":"/issuer/0001341235","owner_cik":"0001836354","owner_name":"Machatha Stephen","owner_display_name":"Machatha Stephen","owner_url":"/insider/0001836354","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18231.0,"shares_display":"18,231","price_per_share":3.4064,"price_display":"3.41","price_state":"stated","total_value":62102.0784,"total_display":"62,102.08","total_whole":"62,102","shares_owned_after":255032.0,"shares_owned_after_display":"255,032","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-11","filed_date":"2024-03-12","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":5,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":5,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":5},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001341235","name":"Aldeyra Therapeutics, Inc.","url":"/issuer/0001341235","role":"Officer (Chief Development Officer)","n_filings":4,"first_seen":"2024-03-12","last_seen":"2025-08-13"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001836354","retrieved_at":"2026-08-25T20:36:42+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}